Literature DB >> 4856406

Cumulative cytostatic effect of ICRF 159.

R C Hallowes, D G West, K Hellmann.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4856406     DOI： 10.1038/247487a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Razoxane in treatment of acute myeloid leukaemia.

Authors: 
Journal:  Br Med J       Date:  1978-10-21

2.  Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Authors:  J M Gilbert; K Hellmann; M Evans; P G Cassell; B Stoodley; H Ellis; C Wastell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.

Authors:  R H Wheeler; D J Clauw; R B Natale; R W Ruddon
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  [The effect of bleomycin, ICRF 159 and of simultaneous X-ray application on CHO-fibroblasts].

Authors:  D Töllner; G Hagemann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977

5.  ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response.

Authors:  C J Kovacs; M J Evans; L L Schenken; D R Burholt
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

6.  Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.

Authors:  I W Taylor; N M Bleehen
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

7.  ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.

Authors:  C J Kovacs; M J Evans; D R Burholt; L L Schenken
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.